146 related articles for article (PubMed ID: 24944783)
1. Systematic conversion to generic tacrolimus in stable kidney transplant recipients.
Rosenborg S; Nordström A; Almquist T; Wennberg L; Bárány P
Clin Kidney J; 2014 Apr; 7(2):151-155. PubMed ID: 24944783
[TBL] [Abstract][Full Text] [Related]
2. Nationwide conversion to generic tacrolimus in pediatric kidney transplant recipients.
Naicker D; Reed PW; Ronaldson J; Kara T; Wong W; Prestidge C
Pediatr Nephrol; 2017 Nov; 32(11):2125-2131. PubMed ID: 28660366
[TBL] [Abstract][Full Text] [Related]
3. The impact of conversion from prograf to generic tacrolimus in liver and kidney transplant recipients with stable graft function.
Momper JD; Ridenour TA; Schonder KS; Shapiro R; Humar A; Venkataramanan R
Am J Transplant; 2011 Sep; 11(9):1861-7. PubMed ID: 21714845
[TBL] [Abstract][Full Text] [Related]
4. Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients.
Staatz CE; Tett SE
Clin Pharmacokinet; 2015 Oct; 54(10):993-1025. PubMed ID: 26038096
[TBL] [Abstract][Full Text] [Related]
5. STABIL-study: The Course of Therapy, Safety and Pharmacokinetic Parameters of Conversion of Prograf® to Tacrolimus HEXAL®/Crilomus® in Renal Transplant Recipients - an Observational Study in Germany.
Lehner LJ; Kalb K; Weigand K; Pein U; Schenker P; Seeger W; Roehle R; Dienes K; Halleck F; Budde K
Curr Rev Clin Exp Pharmacol; 2021; 16(4):357-368. PubMed ID: 33588739
[TBL] [Abstract][Full Text] [Related]
6. A single-centre comparison of the clinical outcomes at 6 months of renal transplant recipients administered Adoport
Connor A; Prowse A; Newell P; Rowe PA
Clin Kidney J; 2013 Feb; 6(1):21-28. PubMed ID: 27818747
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and Clinical Outcomes of Generic Tacrolimus (Hexal) Versus Branded Tacrolimus in De Novo Kidney Transplant Patients: A Multicenter, Randomized Trial.
Arns W; Huppertz A; Rath T; Ziefle S; Rump LC; Hansen A; Budde K; Lehner LJ; Shipkova M; Baeumer D; Kroeger I; Sieder C; Klein T; Schenker P
Transplantation; 2017 Nov; 101(11):2780-2788. PubMed ID: 28658202
[TBL] [Abstract][Full Text] [Related]
8. Impact of conversion from Advagraf to twice-daily generic tacrolimus in kidney transplant recipients: a single-center study.
Melo MJ; Gonçalves J; Guerra JO; Santana A; Nascimento C
Transplant Proc; 2015 May; 47(4):911-3. PubMed ID: 26036484
[TBL] [Abstract][Full Text] [Related]
9. Conversion of stable kidney transplant recipients from a twice daily Prograf-based regimen to a once daily modified release tacrolimus-based regimen.
Alloway R; Steinberg S; Khalil K; Gourishankar S; Miller J; Norman D; Hariharan S; Pirsch J; Matas A; Zaltzman J; Wisemandle K; Fitzsimmons W; First MR
Transplant Proc; 2005 Mar; 37(2):867-70. PubMed ID: 15848559
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of conversion from twice-daily tacrolimus (prograf) to once-daily prolonged-release tacrolimus (graceptor) in stable kidney transplant recipients.
Nakamura Y; Hama K; Katayama H; Soga A; Toraishi T; Yokoyama T; Kihara Y; Jojima Y; Konno O; Iwamoto H; Takeuchi H; Hirano T; Shimazu M
Transplant Proc; 2012 Jan; 44(1):124-7. PubMed ID: 22310595
[TBL] [Abstract][Full Text] [Related]
11. Significant reduction of Tacrolimus trough level after conversion from twice daily Prograf to once daily Advagraf in Chinese renal transplant recipients with or without concomitant diltiazem treatment.
Ma MK; Kwan LP; Mok MM; Yap DY; Tang CS; Chan TM
Ren Fail; 2013 Aug; 35(7):942-5. PubMed ID: 23815459
[TBL] [Abstract][Full Text] [Related]
12. Conversion from Prograf to Advagraf in stable kidney transplant recipients: better renal function after 3-year follow-up.
Spagnoletti G; Gargiulo A; Salerno MP; Favi E; Pedroso JA; Calia R; Romagnoli J; Citterio F
Transplant Proc; 2014 Sep; 46(7):2224-7. PubMed ID: 25242756
[TBL] [Abstract][Full Text] [Related]
13. Conversion of stable liver transplant recipients from a twice-daily Prograf-based regimen to a once-daily modified release tacrolimus-based regimen.
Florman S; Alloway R; Kalayoglu M; Lake K; Bak T; Klein A; Klintmalm G; Busque S; Brandenhagen D; Lake J; Wisemandle K; Fitzsimmons W; First MR
Transplant Proc; 2005 Mar; 37(2):1211-3. PubMed ID: 15848672
[TBL] [Abstract][Full Text] [Related]
14. Envarsus, a novelty for transplant nephrologists: Observational retrospective study.
Franco A; Más-Serrano P; Balibrea N; Rodriguez D; Javaloyes A; Díaz M; Gascón I; Ramon-Lopez A; Perez-Contreras J; Selva J; Nalda-Molina R
Nefrologia (Engl Ed); 2019; 39(5):506-512. PubMed ID: 30850218
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of clinical and safety outcomes associated with conversion from brand-name to generic tacrolimus in transplant recipients enrolled in an integrated health care system.
Spence MM; Nguyen LM; Hui RL; Chan J
Pharmacotherapy; 2012 Nov; 32(11):981-7. PubMed ID: 23074134
[TBL] [Abstract][Full Text] [Related]
16. Generic tacrolimus in solid organ transplantation.
Taube D; Jones G; O'Beirne J; Wennberg L; Connor A; Rasmussen A; Backman L
Clin Transplant; 2014 May; 28(5):623-32. PubMed ID: 24750309
[TBL] [Abstract][Full Text] [Related]
17. A randomized pharmacokinetic study of generic tacrolimus versus reference tacrolimus in kidney transplant recipients.
Alloway RR; Sadaka B; Trofe-Clark J; Wiland A; Bloom RD
Am J Transplant; 2012 Oct; 12(10):2825-31. PubMed ID: 22759200
[TBL] [Abstract][Full Text] [Related]
18. The association between trough blood concentration and systemic exposure of tacrolimus: Comparison between once-daily (Advagraf®) and twice-daily (Prograf®) formulation in de novo kidney transplant recipients.
Sukkha S; Chindavijak B; Nosoongnoen W; Phakdeekitchareon B; Kitiyakara C; Sumethkul V
Drug Metab Pharmacokinet; 2020 Feb; 35(1):139-144. PubMed ID: 31727575
[TBL] [Abstract][Full Text] [Related]
19. Switching Stable Kidney Transplant Recipients to a Generic Tacrolimus Is Feasible and Safe, but It Must Be Monitored.
González F; López R; Arriagada E; Carrasco R; Gallardo N; Lorca E
J Transplant; 2017; 2017():5646858. PubMed ID: 28246556
[No Abstract] [Full Text] [Related]
20. Use of generic tacrolimus in elderly renal transplant recipients: precaution is needed.
Robertsen I; Åsberg A; Ingerø AO; Vethe NT; Bremer S; Bergan S; Midtvedt K
Transplantation; 2015 Mar; 99(3):528-32. PubMed ID: 25148382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
